Literature DB >> 3930110

Interferon-gamma induces HLA-DR expression by thyroid epithelium.

I Todd, R Pujol-Borrell, L J Hammond, G F Bottazzo, M Feldmann.   

Abstract

We recently showed that human thyroid epithelial cells, which are normally negative for HLA-DR molecules, express HLA-DR in thyroid autoimmunity. Furthermore, induction of HLA-DR on normal thyroid cells can be achieved by culture with plant lectins. We have now found that recombinant human interferon-gamma (IFN-gamma) induces expression of HLA-DR molecules on cultured human thyroid cells, whereas Namalva IFN-alpha, recombinant IFN-beta or recombinant interleukin-2 (IL-2) do not. All three IFN, but not IL-2, enhanced thyroid cell HLA-A,B,C expression. The results strongly implicate T cells (which are the source of IFN-gamma) in the aberrant induction of DR on thyroid epithelial cells which is proposed to be a central feature of the immunopathological processes leading to autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930110      PMCID: PMC1577305     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon.

Authors:  J S Pober; T Collins; M A Gimbrone; R S Cotran; J D Gitlin; W Fiers; C Clayberger; A M Krensky; S J Burakoff; C S Reiss
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

2.  Expression of Ia antigen on epidermal keratinocytes is a consequence of cellular immunity.

Authors:  A J Suitters; I A Lampert
Journal:  Br J Exp Pathol       Date:  1982-04

3.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

Authors:  A N Gorsuch; K M Spencer; J Lister; J M McNally; B M Dean; G F Bottazzo; A G Cudworth
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

5.  Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity.

Authors:  E L Khoury; L Hammond; G F Bottazzo; D Doniach
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

6.  Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication.

Authors:  W C Van Voorhis; J Valinsky; E Hoffman; J Luban; L S Hair; R M Steinman
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

7.  Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

Authors:  T Hanafusa; R Pujol-Borrell; L Chiovato; R C Russell; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

8.  Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

Authors:  G F Bottazzo; R Pujol-Borrell; T Hanafusa; M Feldmann
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

9.  Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.

Authors:  G H Wong; I Clark-Lewis; L McKimm-Breschkin; A W Harris; J W Schrader
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization.

Authors:  E B Lane
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

View more
  79 in total

1.  The effect of gamma-interferon on HLA class II antigen expression on isolated human nasal chondrocytes.

Authors:  J Bujia; E Wilmes; F Krombach; C Hammer; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

3.  Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate.

Authors:  S Fais; F Delle Fratte; F Mancini; V Cioni; M Guadagno; G Vetrano; F Pallone
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

4.  The role of interferon gamma in the pathogenesis of Crohn's disease.

Authors:  T Sasaki; N Hiwatashi; H Yamazaki; M Noguchi; T Toyota
Journal:  Gastroenterol Jpn       Date:  1992-02

5.  Protracted diarrhoea of infancy: evidence in support of an autoimmune variant.

Authors:  R Mirakian; A Richardson; P J Milla; J A Walker-Smith; J Unsworth; M O Savage; G F Bottazzo
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

6.  Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; C Shimomura; Y Ueki; H Nakao; H Tezuka; M Matsunaga; T Fukuda; N Ishikawa
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

7.  Class II MHC antigens in the rat digestive system. Normal distribution and induced expression after interferon-gamma treatment in vivo.

Authors:  B Steiniger; P Falk; M Lohmüller; P H van der Meide
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

8.  Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production.

Authors:  K Tamura; J Woo; N Murase; G Carrieri; M A Nalesnik; A W Thomson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

Review 9.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

10.  Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.

Authors:  I C Roura-Mir; L Alcalde; F Vargas; E Tolosa; G Obiols; M Foz; D Jaraquemada; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.